Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
Breast cancer (BC) is the most commonly diagnosed cancer in women and one of the most common causes of cancer-related deaths. Despite intense research efforts, BC treatment still remains challenging. Improved drug development strategies are needed for impactful benefit to patients. Current preclinic...
Guardado en:
Autores principales: | Marco Cavaco, Patrícia Fraga, Javier Valle, David Andreu, Miguel A. R. B. Castanho, Vera Neves |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f01c0e8ba06d4b4390251fcc52ee3d03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrative Bioinformatics Analysis Reveals Possible Target and Mechanism of Ellipticine Against Breast Cancer Stem Cells.
por: Adam Hermawan, et al.
Publicado: (2021) -
Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
por: Benas Balandis, et al.
Publicado: (2021) -
Natural Bioactive Cyclopeptides from Microbes as Promising Anticancer Drug Leads: A Mini-review
por: Linda Sukmarini
Publicado: (2021) -
Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents
por: Mahla Malekzadeh, et al.
Publicado: (2022) -
Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
por: Stephen J. Winter, et al.
Publicado: (2021)